Literature DB >> 7896950

Necrolytic migratory erythema without glucagonoma in patients with liver disease.

M P Marinkovich1, R Botella, J Datloff, O P Sangueza.   

Abstract

BACKGROUND: Necrolytic migratory erythema (NME) is an uncommon inflammatory dermatosis with a distinct clinical and histologic appearance. NME is usually associated with glucagonoma. Only a few cases of NME in the absence of glucagonoma have been previously reported.
OBJECTIVE: We sought to understand further the pathogenesis of NME by analyzing data from three patients.
METHODS: Three patients were examined both clinically and histopathologically.
RESULTS: Each patient had an extensive erythematous scaling eruption in intertriginous, perioral, and acral areas, and a markedly red, smooth tongue. Skin biopsy specimens showed confluent parakeratosis, epidermal pallor, papillary edema, and a lymphohistiocytic infiltrate. Two patients had alcoholic liver disease and one had liver dysfunction as a result of hemochromatosis. Serum albumin level was depressed, and liver enzyme values were increased in all three patients. Glucagonoma was undetectable in these patients.
CONCLUSION: In the absence of glucagonoma, hepatocellular dysfunction and hypoalbuminemia appear to be the most common factors associated with NME.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7896950     DOI: 10.1016/0190-9622(95)90345-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

Review 1.  Etiology and pathogenesis of necrolytic migratory erythema: review of the literature.

Authors:  Emily P Tierney; Joanna Badger
Journal:  MedGenMed       Date:  2004-09-10

2.  [Necrolytic migratory erythema in glucagonoma syndrome].

Authors:  I Stark; C H Mensing; C A Sander
Journal:  Hautarzt       Date:  2008-01       Impact factor: 0.751

Review 3.  Zinc and Skin Disorders.

Authors:  Youichi Ogawa; Manao Kinoshita; Shinji Shimada; Tatsuyoshi Kawamura
Journal:  Nutrients       Date:  2018-02-11       Impact factor: 5.717

4.  How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma?

Authors:  Carmen Sorina Martin; Ovidiu Dumitru Parfeni; Liliana Gabriela Popa; Mara Madalina Mihai; Dana Terzea; Vlad Herlea; Mirela Gherghe; Razvan Adam; Osama Alnuaimi; Valentin Calu; Adrian Miron; Silvius Negoita; Cornelia Nitipir; Simona Fica
Journal:  Diagnostics (Basel)       Date:  2022-01-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.